AIM-HI Accelerator Fund

We have officially kicked-off! #GSAC24 #Cancer #Research

The panel on the Investor Perspective is starting now! Our panelists insights into venture investments in the cancer research space is crucial in the fight against cancer. #GSAC24 #Venture #VentureCapital #Investment #Panel #GlobalSummit | Matt Tremblay, Ph.D. | David Greenwald, Ph.D. | Beverly Lu, PhD | Yosemite | Marie-Claire Peakman | Pfizer | Fei Shen | Boehringer Ingelheim

Please join us in congratulating the 2024 AIM-HI Women’s Venture Competition Award Winners: Nabanita Nawar, Ph.D., Co-Founder & CEO, HDAX Therapeutics, and Paraskevi Giannakakou, Ph.D. Co-Founder & CSO, ARMA Bio. #GSAC24 #EmpoweringWomen #WomenEntrepreneurs

Congratulations to Dr. Margaret Foti on receiving the AIM-HI Beacon Award! #GSAC24 | American Association for Cancer Research | #Research #CureCancer

Our first panel on New Approaches to Cancer Treatments has just begun. Thank you Dr. Lisa Coussens for starting emceeing this session and reminding us why new treatments are still so crucial! #GSAC24 #Cancer #CureCancer #NFCR

3 Days Left Until the 2024 NFCR Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship! We’re just three days away from gathering leading minds in cancer research, entrepreneurship, and patient care. This year’s Global Summit is set to be a pivotal event for innovation and collaboration in the fight against cancer. Special highlights of the event include a morning keynote address from Dr. Drew Pardoll, Director of Bloomberg- Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University School of Medicine; An evening keynote address from Dr. Siddhartha Mukherjee, 2011 Pulitzer Prize Winner and Associate Professor of Medicine at Columbia University; AACR CEO Dr. Margaret Foti, who will receive the 2024 AIM-HI Beacon Award for Women Leaders in Oncology; and Dr. Dennis J. Slamon, who will be honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research. Find out about the full program details here: https://bit.ly/3zcI1B1 #NFCRGlobalSummit #AwardCeremonies #OncologyCommunity #Networking #Collaboration #AIMHIaccelerator National Foundation for Cancer Research (NFCR) OncoDaily Asian Fund for Cancer Research

The countdown is on—just 8 days left until the highly anticipated Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship! This year’s event is shaping up to be truly exceptional, with groundbreaking discussions from world-renowned experts and thought leaders who are pioneering the future of cancer research. From innovative treatments to patient-centered approaches, every session will offer valuable insights that could reshape how we tackle cancer moving forward. Are you ready to join us? #BeatCancer #CureCancer #Cancer #Research #CancerResearch #GSAC24 #InnovationInCancer #FutureOfResearch #GlobalSummit #Venture

Dr. Sujuan Ba, AIM-HI CEO & Co-Founder, attended the Chinese American Hematologists and Oncologists Network (CAHON)’s 11th New York Oncology Forum this past weekend, where more than 100 physicians and clinical researchers around the US gathered to share compelling data and ideas to advance science and positively impact cancer patients.  Dr. Ba served on the panel discussing "Bridging Clinical Trial and Research Collaboration." It was an inspiring and stimulating discussion about how we can bridge and collaborate to improve the quality and efficiency of clinical trials and advance innovative therapies from research labs to patients' bedsides.  #Oncology #Collaboration #Innovation #WeDriveCuresForward

Join Us at the 2024 NFCR Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship! We believe that when visionary leaders from across cancer research, entrepreneurship, and patient care come together, true progress happens. That's why the National Foundation for Cancer Research (NFCR) and AIM-HI Accelerator Fund have curated the annual Global Summit, bringing top minds under one roof to drive innovation and collaboration in the fight against cancer. This is more than just a conference— it provides a space for sharing ideas, building connections, and working together on driving cures forward. We encourage you to take part in this important gathering that aims to shape the future of cancer treatment. Date: October 18, 2024 Location: The National Press Club, Washington, DC Read about the speakers and program and register today at: https://bit.ly/3zcI1B1 #NFCRGlobalSummit #AwardCeremonies #OncologyCommunity #Networking #AIMHIaccelerator OncoDaily Asian Fund for Cancer Research Ignacio (Nacho) Asial Peikwen Cheng

Exciting Update! AIM-HI portfolio company, Tvardi Therapeutics, a privately held, clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases, announced that John Kauh, M.D., Chief Medical Officer, will present a poster at the American College of Chest Physicians (CHEST) 2024 Annual Meeting, which is being held October 6-9, in Boston, Massachusetts.  Learn More: https://bwnews.pr/3Ndui0n #oncology #AIMHIaccelerator #WeDriveCuresForward OncoDaily